Crossmark

Study protocol for a multi-site randomized clinical trial of an intervention program to promote self-management among head and neck cancer survivors with lymphedema and fibrosis [PROMISE trial]

Crossref DOI link: https://doi.org/10.1186/s13063-025-09089-x

Published Online: 2025-10-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Deng, Jie https://orcid.org/0000-0002-2553-8822
Abene, Jessica

Huang, Liming

Murphy, Barbara A.
Funding

Funding for this research was provided by:

U.S. Department of Defense
License Information

Text and Data Mining valid from 2025-10-13

Version of Record valid from 2025-10-13
More Information

Article History

Received: 23 September 2024

Accepted: 19 August 2025

First Online: 13 October 2025

Declarations

:

: This study protocol was fully reviewed and approved by the Institutional Review Board of the University of Pennsylvania and the Institutional Review Board of Vanderbilt University. Trained staff will obtain an informed consent form from every participant.

: Not applicable

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below